Top Markets
Coin of the day
Enimmune corporation Enimmune corporation

Enimmune corporation

6564
Classement en actions #26781
Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused... Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused on the research, development, and commercialization of pharmaceutical products. Among its key offerings is Tuberculin PPD RT23 SSI, an approved diagnostic agent utilized in tuberculin tests to ascertain the presence of tuberculosis infection in patients. Beyond its existing products, Enimmune is heavily invested in developing vaccines aimed at combating a diverse array of infectious diseases. These include, but are not limited to, vaccines for enterovirus, pneumonia, norovirus, dengue fever, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Established in 2014, the company maintains its headquarters in Taichung City, Taiwan.
Prix de l'action
$0.52468396
Capitalisation boursière
$37.85M
Changement (1 jour)
1.23%
Changement (1 an)
-4.53%
Pays
TW
Échange Enimmune corporation (6564)

Catégorie

Le prix 6564 avec la capitalisation boursière de B
Enimmune corporation Enimmune corporation
6564
$0.52468396
Capitalisation boursière de Enimmune corporation(6564)
Capitalisation boursière: $37.85M
En August 2026, Enimmune corporation a une capitalisation boursière de $37.85M. Cela fait de Enimmune corporation la 26781st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Enimmune corporation du 2018 au 2026
6564 par rapport au top 5 des plus populaires stocks
Prix pour 6564 L’actif B La capitalisation boursière de B Résultats
Enimmune corporation Enimmune corporation
$73,481.63 $37.85M
$5.301T +14,004,830.93%
Enimmune corporation Enimmune corporation
$64,235.55 $37.85M
$4.634T +12,242,612.46%
Enimmune corporation Enimmune corporation
$57,430.78 $37.85M
$4.143T +10,945,684.72%
Enimmune corporation Enimmune corporation
$49,756.56 $37.85M
$3.589T +9,483,048.37%
Enimmune corporation Enimmune corporation
$39,603.56 $37.85M
$2.857T +7,547,978.62%